James E. Flynn - Mar 20, 2025 SCHEDULE 13D/A Report for ARS Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (SPRY)

Filing Manager
Flynn James E
Reporting Manager
Deerfield Management Company, L.P.
Security
ARS Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
Symbol
SPRY
Shares outstanding
98.1M shares
Disclosed Ownership
10.5M shares
Ownership
10.7%
Form type
SCHEDULE 13D/A
Date filed
3/24/2025, 07:57 PM
Date of event
Mar 20, 2025
Next filing
Jul 2, 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deerfield Mgmt III, L.P. 5.36% 5.26M 0 5.26M /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001610540
Deerfield Private Design Fund III, L.P. 5.36% 5.26M 0 5.26M /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001603333
Deerfield Mgmt IV, L.P. 5.36% 5.26M 0 5.26M /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001713467
Deerfield Private Design Fund IV, L.P. 5.36% 5.26M 0 5.26M /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001680307
Deerfield Management Company, L.P. 10.72% 10.5M 0 10.5M /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001009258
James E. Flynn 10.72% 10.5M 0 10.5M /s/ Jonathan Isler Jonathan Isler, Attorney-in-Fact 0001352546